Participation Statistics
& ESID Society Info

INDUSTRY BENEFITS OF SUPPORTING ESID 2022

  • World’s largest and most important meeting devoted to Primary Immunodeficiencies.​
  • Promotes cutting-edge scientific research
  • Contributes to the advancement of Primary Immunodeficiencies on an international level
  • Offers a unique opportunity to exchange ideas with renowned professionals from across the world
  • Provides an ideal networking forum
  • Offers unique exposure to worldwide markets

ESID Attendance over the years

ESID 2010 (Istanbul) - 1,300 Participants
ESID 2012 (Florence) - 1,838 Participants
ESID 2014 (Prague) - 2,098 Participants
ESID 2017 Focus Meeting (Edinburgh) - 1,628 Participants
ESID 2018 (Lisbon) - 2,475 Participants
ESID 2019 Focus Meeting (Brussels) - 1,669 Participants
ESID 2020 (Virtual) - 1,969 Participants
ESID 2021 Focus Meeting - Secondary Immunodeficiencies (Virtual) - 1,085 Participants

Statistics from ESID 2021 – Virtual

Total registrations

Countries Represented

Total Number of Unique Logins

Total Number of User Logins

TOTAL UNIQUE USERS LOGINS BY DAY

Top 20 Countries (%)

  • TURKEY 9%
  • UNITED KINGDOM 9%
  • POLAND 7%
  • SPAIN 6%
  • ITALY 5%
  • GERMANY 4%
  • UNITED STATES 4%
  • BRAZIL 4%
  • NETHERLANDS 3%
  • SWITZERLAND 3%
  • IRELAND 3%
  • FRANCE 3%
  • AUSTRIA 2%
  • MEXICO 2%
  • ARGENTINA 2%
  • PORTUGAL 2%
  • AUSTRALIA 2%
  • BELGIUM 2%
  • CANADA 2%
  • DENMARK 2%

World Regions (%)

PARTICIPANTS BY AGE (%)

  • 18-30
  • 31-40
  • 41-50
  • 51-60
  • 60+

PARTICIPANTS BY PROFESSIONAL ROLE (%)

  • Clinical Practitioner
  • Clinician Researcher
  • Other
  • Resident/Research Fellow
  • Industry/Corporate Professional
  • Nurse/Healthcare Practitioner
  • Basic Science Researcher
  • Student

PARTICIPANTS BY WORKPLACE (%)

  • Hospital
  • University Hospital
  • Industry
  • Laboratory
  • Other
  • University
  • Research Institute
  • Private Practice
  • Comprehensive Care Clinic

PROFESSIONAL INTEREST BY FIELD (%)

  • Immunology
  • Allergy & Clinical Immunology
  • Pediatrics
  • Other
  • Internal Medicine
  • Hematology
  • Rheumatology
  • Pharmacology
  • Molecular Biology

COMMITMENT TO THE HIGHEST STANDARDS IN CME/CPD

Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by:

CME.PNG
  • Championing best practice in CME/CPD
  • Maintaining and improving standards
  • Mentoring and educating
  • Working in collaboration with critical stakeholders

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.

CME Accreditation

An application will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME) to provide accreditation by the following CME activity for medical specialists. The EACCME is an institution of the European

Union of Medical Specialists (UEMS): www.uems.net.

Industry Supported Sessions

Industry Supported Sessions slots are offered to industry as non-CME commercial/promotional sessions that are not accredited. As such supporters are free to choose their topics, invite speakers and control content, the session will be

indicated in the program as organized by the Supporter. Topic and program are subject to approval by the Congress Scientific Committee.

Disclaimer

Information contained in the scientific program must comply with the applicable CME/CPD regulations. Scientific/Educational Program shall not include any commercial elements such as company names, products names, etc. Commercial information shall be kept separate and clearly differentiated from the scientific accredited content. Non educational activities may include promotional elements and shall not be accredited.​​​

   Sign up for updates    LinkedIn    YouTube